SCHEMBL13160337

SCHEMBL13160337

CCc1c(C)nc(-c2cn[nH]c2)c(C)c1C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.38
ALDH1A1 P00352 2/20 0.38
ADORA2A P29274 2/20 0.36
ADORA1 P30542 2/20 0.36
MTOR P42345 2/20 0.34
PGK1 P00558 1/20 0.34
KCNH2 Q12809 1/20 0.34
AKT1 P31749 1/20 0.34
AKT2 P31751 1/20 0.34
GRM4 Q14833 2/20 0.33
LMNA P02545 2/20 0.33
GPR35 Q9HC97 1/20 0.33
GRM8 O00222 1/20 0.33
PIM1 P11309 1/20 0.33
PIM3 Q86V86 1/20 0.33
PIM2 Q9P1W9 1/20 0.33
APEX1 P27695 1/20 0.33
PMP22 Q01453 1/20 0.33
MAPK8 P45983 1/20 0.33
KDM5A P29375 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26242523 0.70 KCNH2 (0.40) KDM4EALDH1A1ADORA2AADORA1MTOR
SCHEMBL13160088 0.69 KDM5B (0.38) KDM4EALDH1A1LMNAPIM1PIM3
SCHEMBL19003127 0.66 KCNH2 (0.43) KDM4EALDH1A1ADORA2AADORA1KCNH2
SCHEMBL10272396 0.66 AKT2 (0.42) AKT1AKT2PIM1PIM3PIM2
SCHEMBL21193154 0.66 KDM4E (0.42) KDM4EALDH1A1ADORA2AADORA1MTOR
SCHEMBL21193333 0.65 KCNH2 (0.41) KDM4EALDH1A1ADORA2AADORA1MTOR
SCHEMBL19914001 0.65 PIM1 (0.39) KDM4EALDH1A1KCNH2AKT1AKT2
SCHEMBL25675415 0.64 CDC7 (0.34) KDM4EALDH1A1KDM5AHSD17B10KDM5B
SCHEMBL16049353 0.64 PDPK1 (0.40) MTORMAPK1
SCHEMBL14983683 0.63 MAPK1 (0.50) KDM4EALDH1A1KCNH2AKT1AKT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010117425-A1 CERTAIN SUBSTITUTED PYRIMIDINES, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS FOR THEIR USE BIOGEN IDEC MA INC. (US) 2010-10-14 WO disclosed